Evidence map›Paper›PMID 31547091›Full record

ArticleMetabolites2019

Unravelling the Metabolic Reconfiguration of the Post-Challenge Primed State in

Fidele Tugizimana, Paul A Steenkamp, Lizelle A Piater, Nico Labuschagne, Ian A Dubery

Abstract read
In one paragraph

Article in Metabolites, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Early and Late Transcriptomic and Metabolomic Responses ofInternational journal of molecular sciences · 2023
    Article
  9. Article
  10. The Luteolinidin and Petunidin 3-Molecules (Basel, Switzerland) · 2022
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Article
  18. Review
  19. Understanding the Sorghum-Frontiers in plant science · 2021
    Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Fidele TugizimanaResearch Centre for Plant Metabolomics, Department of Biochemistry, University of Johannesburg, Auckland Park, Johannesburg 2006, South Africa. ftugizimana@uj.ac.za.ORCID 0000-0001-8172-6599
Paul A SteenkampResearch Centre for Plant Metabolomics, Department of Biochemistry, University of Johannesburg, Auckland Park, Johannesburg 2006, South Africa. psteenkamp@uj.ac.za.ORCID 0000-0002-4416-6796
Lizelle A PiaterResearch Centre for Plant Metabolomics, Department of Biochemistry, University of Johannesburg, Auckland Park, Johannesburg 2006, South Africa. lpiater@uj.ac.za.ORCID 0000-0002-9526-0109
Nico LabuschagneDepartment of Plant and Soil Science, University of Pretoria, Hatfield, Pretoria 0028, South Africa. nico.labuschagne@up.ac.za.ORCID 0000-0001-7170-2294
Ian A DuberyResearch Centre for Plant Metabolomics, Department of Biochemistry, University of Johannesburg, Auckland Park, Johannesburg 2006, South Africa. idubery@uj.ac.za.ORCID 0000-0002-9079-4769

Funding

National Research Foundation 95818
6 · The paper itself

Abstract

Priming is a natural phenomenon that pre-conditions plants for enhanced defence against a wide range of pathogens. It represents a complementary strategy, or sustainable alternative that can provide protection against disease. However, a comprehensive functional and mechanistic understanding of the various layers of priming events is still limited. A non-targeted metabolomics approach was used to investigate metabolic changes in plant growth-promoting rhizobacteria (PGPR)-primed

Indexed as

chemometricsLC-MSmetabolomicsPGPRplant primingsecondary metabolitessorghum

Identifiers

PMID31547091
PMCPMC6835684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.